Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The medical technology group focused on the durable healing of wounds and the prevention of amputations, today announces that topical oxygen therapy is included in the National Institute for Health and Care Excellence updated Diabetic Foot Problems: Prevention and Management guideline, and the Company's Topical Wound Oxygen therapy is now active on the Advanced Wound Care framework, awarded by NHS Supply Chain.</li>
<li>The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2 therapy to improve outcomes in difficult-to-heal wounds.</li>
</ul>


The medical technology group focused on the durable healing of wounds and the prevention of amputations, today announces that topical oxygen therapy is included in the National Institute for Health and Care Excellence updated Diabetic Foot Problems: Prevention and Management guideline, and the Company's Topical Wound Oxygen therapy is now active on the Advanced Wound Care framework, awarded by NHS Supply Chain.
The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2 therapy to improve outcomes in difficult-to-heal wounds.


Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

United Kingdom

Videndum PLC designs, manufactures and distributes camera supports, camera mounted electronic accessories, robotic camera systems, prompters, LED lights, mobile power, monitors, bags, motion control, smart phone accessories, audio capture, and noise reduction equipment.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Videndum (VID LN)

Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)